2025 Annual Meeting | C61 - Essentials of Diagnosis and Management of Hemorrhagic Stroke

Date Sunday 04/06/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 31AB

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Claude Hemphill III, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants should become familiar with the emergency evaluation of patients with acute intracerebral hemorrhage, including initial emergency evaluation and acutely administered treatments. Special attention will be paid to appropriate referral for neurosurgical intervention and implementation of a bundled care approach including multiple different concurrent therapies. Case-based discussion of prognostic decision-making will also be emphasized.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Intracerebral Hemorrhage - Focus on Intervention Claude Hemphill III, MD, FAAN
01:05 PM - 01:30 PM PDT	Speaker	Code Stroke - What If It Is an Intracerebral Hemorrhage? Aleksandra Yakhkind, MD
01:30 PM - 01:55 PM PDT	Speaker	Who Needs Surgical Intervention for Intracerebral Hemorrhage? Wendy C. Ziai, MD
01:55 PM - 02:20 PM PDT	Speaker	Bundles of Care for Intracerebral Hemorrhage - Acute Care and Recovery Claude Hemphill III, MD, FAAN
02:20 PM - 02:50 PM PDT	Discussion	Case-based Discussions of Prognostic Decision-making Claude Hemphill III, MD, FAAN, Aleksandra Yakhkind, MD, Wendy C. Ziai, MD
02:50 PM - 03:00 PM PDT	Q&A	Questions and Answers Claude Hemphill III, MD, FAAN, Aleksandra Yakhkind, MD, Wendy C. Ziai, MD

Faculty Disclosures
Claude Hemphill III, MD, FAAN	Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
Aleksandra Yakhkind, MD	Dr. Yakhkind has a non-compensated relationship as a Faculty with Massachusetts General Hospital CME that is relevant to AAN interests or activities.
Wendy C. Ziai, MD	Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lumosa. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bard. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ.

��ɫ��

��ɫ��